PCN25 DRUG UTILIZATION AND COSTS FOR ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN PATIENTS WITH BREAST, LUNG, OR GASTROINTESTINAL CANCER RECEIVING CHEMOTHERAPY
May 1, 2009, 00:00
10.1016/S1098-3015(10)73262-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)73262-9/fulltext
Title :
PCN25 DRUG UTILIZATION AND COSTS FOR ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN PATIENTS WITH BREAST, LUNG, OR GASTROINTESTINAL CANCER RECEIVING CHEMOTHERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73262-9&doi=10.1016/S1098-3015(10)73262-9
First page :
Section Title :
Open access? :
No
Section Order :
687